Post-implementation Critical Narratives

  • Hugh T. MillerEmail author


In this chapter the focus is on the U.S. Drug Enforcement Administration, whose genesis narrative is the War on drugs narrative of the early 1970s. As a fully institutionalized narrative, the agency attracts critical commentary as expressed in the Futility narrative and in various conspiracy narratives that criticize the maintenance of status quo practices. The scheduling of illegal drugs is discussed, as is pressure from members of Congress to influence the DEA’s enforcement or non-enforcement of the Controlled Substances Act with respect to state-level medical cannabis legalization. The DEA is required to implement other agencies’ determinations regarding the medical status of cannabis. Congress is able to withhold funding for would-be DEA efforts to enforce cannabis in states that have legalized it.


War on drugs narrative Futility narrative Drug scheduling Controlled Substances Act Drug Enforcement Administration 


  1. Angell, Tom. 2018. This Man Is the Reason Congress Can’t Vote on Marijuana Anymore. Marijuana Moment, Feb 21. Accessed 24 Jan 2019.
  2. Angell, Tom. 2019. Congress Votes to Block Feds from Enforcing Marijuana Laws in Legal States. Forbes, June 20. Accessed 21 June 2019.
  3. Baum, Dan. 2016. Legalize It All: How to Win the War on Drugs. Harper’s Magazine, Apr. Accessed 20 May 2018.
  4. Bertram, Eva, Morris Blachman, Kenneth Sharpe, and Peter Andreas. 1996. Drug Was Politics: The Price of Denial. Berkeley and Los Angeles: University of California Press.Google Scholar
  5. Cannifornian. 2018. Lawsuit Challenging Sessions and DEA on Marijuana’s Schedule I Status Dismissed by Federal Judge. The Mercury News, Feb 28. Accessed 26 Jan 2019.
  6. Chen, Angus. 2017. Some of the Parts: Is Marijuana’s “Entourage Effect” Scientifically Valid? Scientific American, Apr 20. Accessed 28 Dec 2019.
  7. 2014. H.Amdt.748 to H.R.4660. Accessed 22 May 2019.
  8. DEA. 2016. Schedule of Controlled Substances: Maintaining Marijuana in Schedule I of the Controlled Substances Act. Prepared by Office of Diversion Control, Drug and Chemical Evaluation Section. Washington, DC: U.S. Department of Justice.Google Scholar
  9. DEA. 2018. DEA Internal Directive Regarding the Presence of Cannabinoids in Products and Materials Made from the Cannabis Plant. Diversion Control Division, May 22. Accessed 22 Jan 2019.
  10. DEA. 2019a. Controlled Substances, Alphabetic Order. May 2. Accessed 21 May 2019.
  11. DEA. 2019b. Staffing and Budget. Accessed 22 May 2019.
  12. Degenhardt, Louisa, Wai-Tat Chiu, Nancy Sampson, Ronald C. Kessler, James C. Anthony, Matthias Angermeyer, Ronny Bruffaerts, et al. 2008. Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys. PLoS Medicine 5 (7): 1054–1067.CrossRefGoogle Scholar
  13. DiMasi, Joseph A., Henry G. Grabowski, and Ronald W. Hansen. 2016. Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs. Journal of Health Economics 47 (May): 20–33.CrossRefGoogle Scholar
  14. Drug Policy Alliance. n.d. Asset Forfeiture Reform. Accessed 25 May 2019.
  15. Dufton, Emily. 2017. Grass Roots: The Rise and Fall and Rise of Marijuana in America. New York: Basic Books.Google Scholar
  16. Fang, Lee. 2012a. The Top Five Special Interest Groups Lobbying to Keep Marijuana Illegal. Republic Report, Apr 20. Accessed 25 May 2019.
  17. Fang, Lee. 2012b. Exclusive: Why Can’t You Smoke Pot? Because Lobbyists Are Getting Rich Off of the War on Drugs. Republic Report.
  18. Fang, Lee. 2016. Alcohol Industry Bankrolls Fight Against Legal Pot in Battle of the Buzz. The Intercept, Sept 14. Accessed 25 May 2019.
  19. Fleischman, William, and Joseph S. Ross. 2019. How Insys Undermined an FDA Effort to Protect the Public from Dangerous Opioids. Stat, May 10. Accessed 23 May 2019.
  20. Godlee, Fiona. 2018. Drugs Should Be Legalised, Regulated, and Taxed. The British Medical Journal. BMJ 2018;361:k2057. (Published 10 May 2018). Accessed 12 Apr 2019.
  21. Goodsell, Charles T. 2011. Mission Mystique: Belief Systems in Public Agencies. Washington, DC: CQ Press.CrossRefGoogle Scholar
  22. Hajer, Maarten A. 1995. The Politics of Environmental Discourse: Ecological Modernization and the Policy Process. Oxford: Clarendon Press.Google Scholar
  23. Hajer, Maarten A. 2005. Coalitions, Practices, and Meaning in Environmental Politics: From Acid Rain to BSE (Chapter 12). In Discourse Theory in European Politics: Identity, Policy and Governance, ed. David Howarth and Jacob Torfing, 297–315. Houndmills, Basingstoke, and Hampshire, UK: Palgrave Macmillan.CrossRefGoogle Scholar
  24. Hamblin, James. 2019. The Mushrooms Are Slowly Taking Effect. The Atlantic, May 16. Accessed 13 Aug 2019.
  25. Herer, Jack. 2000. The Emperor Wears No Clothes: The Authoritative Historical Record of Cannabis and the Conspiracy Against Marijuana, 11th ed. Oakland, CA: Quick American Archives. Also available at
  26. Higdon, James. 2018. Washington’s Most Powerful Anti-Pot Official Is Named Sessions. It’s Not Who You Think. Politico Magazine, Mar 21. Accessed 18 Dec 2019.
  27. Higdon, James. 2019. Why 2019 Could Be Marijuana’s Biggest Year Yet. Politico, Jan 21. Accessed 24 Jan 2019.
  28. Hoffmann, Diane, Francis B. Palumbo, and Y. Tony Yang. 2018. Will the FDA’s Approval of Epidiolex Lead to Rescheduling Marijuana? Health Affairs Blog. Accessed 22 Jan 2019.
  29. Horn, Joshua, and Jesse M. Harris. 2019. The 2018 Farm Bill, Hemp and Interstate Commerce. New Jersey Law Journal, June 21. Accessed 21 June 2019.
  30. Hurley, Richard. 2018. Illicit Drug Use Should Not Be a Crime, Says Royal College of Physicians. The British Medical Journal. BMJ 2018;361:k1832. (Published 25 Apr 2018). Accessed 12 Apr 2019.
  31. Iannelli, Jerry. 2018. Sessions’ Pot Crackdown Is Great for South Florida’s Giant Private-Prison Company. Miami New Times, Jan 5. Accessed 12 Mar 2019.
  32. Kingdon, John. 1984. Agendas, Alternatives and Public Policies. New York: HarperCollins.Google Scholar
  33. Levin, Sam. 2017. Big Pharma’s Anti-Marijuana Stance Aims to Squash the Competition, Activists Say. The Guardian, Apr 3. Accessed 25 May 2019.
  34. Lindblom, Charles E. 1959. The Science of “Muddling Through”. Public Administration Review 19 (2): 79–88.CrossRefGoogle Scholar
  35. LoBianco, Tom. 2016. Report: Aide Says Nixon’s War on Drugs Targeted Blacks, Hippies. CNN Politics, Mar 24. Accessed 21 May 2019.
  36. Lopez, German. 2017. The 3 Deadliest Drugs in America Are Legal. Vox, Jan 17. Accessed 24 May 2019.
  37. Mayo, Michael. 2008. Pembroke Pines Shooting Raid: Trash Yields Probable Cause. Sun-Sentinel, June 26.
  38. Misulonas, Joseph. 2018. Meet the Republican Who Is Preventing Congress from Voting on Any Marijuana Bills. Civilized Life. Accessed 19 Dec 2019.
  39. Newman, Tony, and Grant Smith. 2018. Trump Budget Doubles Down on Drug War. Drug Policy Alliance. Accessed 22 May 2019.
  40. Ostrowski, James. 1990. Thinking About Drug Legalization. In Crisis in Drug Prohibition, ed. David Boaz, 45–76. Washington, DC: Cato Institute.Google Scholar
  41. Pisanti, Simona, and Maurizio Bifulco. 2018. Medical Cannabis: A Plurimillennial History of an Evergreen. Journal of Cellular Physiology. Accessed 27 Jan 2019.
  42. Reed, Jason, and Paul Whitehouse. 2018. Harsher Drug Prohibition Won’t Stop Violence, but Regulation Might. The British Medical Journal. BMJ 2018;361:k1999. (Published 8 May 2018). Accessed 12 Apr 2019.
  43. Reilly, Mollie. 2015. Medical Marijuana Dispensaries Win Battle Against Federal Crackdown. Huffpost. Accessed 22 Jan 2019.
  44. Roberts, Mark. 2018. Communication Breakdown: Understanding the Role of Policy Narratives in Political Conflict and Consensus. Critical Policy Studies 12 (1): 82–102.Google Scholar
  45. Stone, Deborah. 2012. Policy Paradox: The Art of Political Decision Making, 3rd ed. New York: W. W. Norton.Google Scholar
  46. Turnbull, Andy. 2005. The System: It’s How the World Works. Toronto: Red Ear Publishing.Google Scholar
  47. WBUR. 2017. ‘We Have to Change the Culture’: Acting Head of DEA on Fighting the Opioid Epidemic. Here & Now, Aug 2. Accessed 22 Jan 2019.
  48. Wedell, Katie. 2018. “No Such Thing as Medical Marijuana,” Health Secretary Says at Dayton-Area Visit. Dayton Daily News, Mar 2. Accessed 22 Jan 2019.

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.School of Public AdministrationFlorida Atlantic UniversityBoca RatonUSA

Personalised recommendations